{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:05:36Z","timestamp":1794251136284,"version":"4.9.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10787-025-01813-y","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:22:15Z","timestamp":1749702135000},"page":"3671-3678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Unravelling the gut\u2013skin axis: the role of gut microbiota in pathogenesis and management of psoriasis"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4212-5892","authenticated-orcid":false,"given":"Arun","family":"Pachauri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"issue":"1","key":"1813_CR1","doi-asserted-by":"publisher","first-page":"4549134","DOI":"10.1155\/2022\/4549134","volume":"2022","author":"A Akbarzadeh","year":"2022","unstructured":"Akbarzadeh A, Alirezaei P, Doosti-Irani A, Mehrpooya M, Nouri F (2022) The efficacy of Lactocare\u00ae synbiotic on the clinical symptoms in patients with psoriasis: a randomized, double-blind, placebo-controlled clinical trial. Dermatol Res Pract 2022(1):4549134","journal-title":"Dermatol Res Pract"},{"issue":"1","key":"1813_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s13668-025-00632-5","volume":"14","author":"G Annunziata","year":"2025","unstructured":"Annunziata G, Verde L, Zink A, Muscogiuri G, Albanesi C, Paganelli A, Barrea L, Scala E (2025) Plant-based foods for chronic skin diseases: a focus on the mediterranean diet. Curr Nutr Rep 14(1):42","journal-title":"Curr Nutr Rep"},{"issue":"15","key":"1813_CR3","doi-asserted-by":"publisher","first-page":"1427770","DOI":"10.3389\/fmicb.2024.1427770","volume":"4","author":"J Chai","year":"2024","unstructured":"Chai J, Deng F, Li Y, Wei X, Zhao J (2024) The gut-skin axis: interaction of gut microbiome and skin diseases. Front Microbiol 4(15):1427770","journal-title":"Front Microbiol"},{"issue":"10","key":"1813_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/j.1398-9995.2008.01741.x","volume":"63","author":"G Ciprandi","year":"2008","unstructured":"Ciprandi G, Colombo BM, Contini P, Cagnati P, Pistorio A, Puppo F, Murdaca G (2008) Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis. Allergy 63(10):1335\u20138","journal-title":"Allergy"},{"issue":"1","key":"1813_CR5","first-page":"5","volume":"6","author":"VS Criton","year":"2024","unstructured":"Criton VS, Joy S (2024) Beyond skincare routines: Follow your gut to healthy skin: a review of the interplay between gut microbiome and skin. J Skin Sexually Trans Dis 6(1):5\u201312","journal-title":"J Skin Sexually Trans Dis"},{"key":"1813_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12915-017-0454-7","volume":"15","author":"ER Davenport","year":"2017","unstructured":"Davenport ER, Sanders JG, Song SJ, Amato KR, Clark AG, Knight R (2017) The human microbiome in evolution. BMC Biol 15:1\u20132","journal-title":"BMC Biol"},{"issue":"6","key":"1813_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4103\/2229-5178.193906","volume":"7","author":"S Dogra","year":"2016","unstructured":"Dogra S, Mahajan R (2016) Psoriasis: epidemiology, clinical features, co-morbidities, and clinical scoring. Ind Dermatol Online J 7(6):471\u201380","journal-title":"Ind Dermatol Online J"},{"issue":"76","key":"1813_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.4103\/0378-6323.72443","volume":"1","author":"S Dogra","year":"2010","unstructured":"Dogra S, Yadav S (2010) Psoriasis in India: prevalence and pattern. Ind J Dermatol Venereol Leprol 1(76):595","journal-title":"Ind J Dermatol Venereol Leprol"},{"key":"1813_CR9","doi-asserted-by":"crossref","unstructured":"Frasier K, Johnson A, Fritts H (2025) The Gut-Skin Axis: unraveling the interplay between gut microbiota and dermatological health. Clin Dermatol Surg 2(2)","DOI":"10.61853\/cfat2e68"},{"issue":"1","key":"1813_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/pharmaceutics17010056","volume":"17","author":"Y Gao","year":"2025","unstructured":"Gao Y, Xu T, Wang Y, Hu Y, Yin S, Qin Z, Yu H (2025) Pathophysiology and treatment of psoriasis: from clinical practice to basic research. Pharmaceutics 17(1):56","journal-title":"Pharmaceutics"},{"issue":"4","key":"1813_CR11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3390\/pathogens14040358","volume":"14","author":"Y Gao","year":"2025","unstructured":"Gao Y, Lou Y, Hui Y, Chen H, Sang H, Liu F (2025) Characterization of the gut microbiota in patients with psoriasis: a systematic review. Pathogens 14(4):358","journal-title":"Pathogens"},{"issue":"10","key":"1813_CR12","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/s41591-018-0164-x","volume":"24","author":"Y He","year":"2018","unstructured":"He Y, Wu W, Zheng HM, Li P, McDonald D, Sheng HF, Chen MX, Chen ZH, Ji GY, Zheng ZD, Mujagond P (2018) Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nat Med 24(10):1532\u20135","journal-title":"Nat Med"},{"issue":"7","key":"1813_CR13","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3390\/biom13071100","volume":"13","author":"E Hern\u00e1ndez","year":"2023","unstructured":"Hern\u00e1ndez E, \u00c1lvarez M, V\u00e1zquez A, Luna S (2023) Microbiota and IL-33\/31 axis linkage: implications and therapeutic perspectives in atopic dermatitis and psoriasis. Biomolecules 13(7):1100","journal-title":"Biomolecules"},{"issue":"15","key":"1813_CR14","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.3390\/jcm10153199","volume":"10","author":"M Honma","year":"2021","unstructured":"Honma M, Nozaki H (2021) Molecular pathogenesis of psoriasis and biomarkers reflecting disease activity. J Clin Med 10(15):3199","journal-title":"J Clin Med"},{"issue":"1","key":"1813_CR15","doi-asserted-by":"publisher","first-page":"2473524","DOI":"10.1080\/19490976.2025.2473524","volume":"17","author":"M Jimenez-Sanchez","year":"2025","unstructured":"Jimenez-Sanchez M, Celiberto LS, Yang H, Sham HP, Vallance BA (2025) The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential. Gut Microbes 17(1):2473524","journal-title":"Gut Microbes"},{"issue":"4","key":"1813_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231197","volume":"15","author":"K Kaur","year":"2020","unstructured":"Kaur K, Khatri I, Akhtar A, Subramanian S, Ramya TN (2020) Metagenomics analysis reveals features unique to Indian distal gut microbiota. PloS ONE 15(4):e0231197","journal-title":"PloS ONE"},{"issue":"6","key":"1813_CR17","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bjd.17989","volume":"181","author":"EA Langan","year":"2019","unstructured":"Langan EA, K\u00fcnstner A, Miodovnik M, Zillikens D, Tha\u00e7i D, Baines JF, Ibrahim SM, Solbach W, Knobloch JK (2019) Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis. Br J Dermatol 181(6):1254\u201364","journal-title":"Br J Dermatol"},{"key":"1813_CR18","unstructured":"Lee SY, Kim YH, Seo JH (2024) Immunological aspects of probiotics for improving skin diseases: influence on the Gut-Brain-Skin Axis. Nutr Rev"},{"issue":"1","key":"1813_CR19","doi-asserted-by":"publisher","first-page":"2096995","DOI":"10.1080\/19490976.2022.2096995","volume":"14","author":"MR Mahmud","year":"2022","unstructured":"Mahmud MR, Akter S, Tamanna SK, Mazumder L, Esti IZ, Banerjee S, Akter S, Hasan MR, Acharjee M, Hossain MS, Pirttil\u00e4 AM (2022) Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases. Gut Microbes 14(1):2096995","journal-title":"Gut Microbes"},{"issue":"12","key":"1813_CR20","first-page":"1078","volume":"99","author":"V Navarro-L\u00f3pez","year":"2019","unstructured":"Navarro-L\u00f3pez V, Mart\u00ednez-Andr\u00e9s A, Ram\u00edrez-Bosc\u00e1 A, Ruzafa-Costas B, N\u00fa\u00f1ez-Delegido E, Carri\u00f3n-Guti\u00e9rrez MA, Prieto-Merino D, Codo\u00f1er-Cort\u00e9s F, Ram\u00f3n-Vidal D, Genov\u00e9s-Mart\u00ednez S, Chenoll-Cuadros E (2019) Efficacy and safety of oral administration of a mixture of probiotic strains in patients with psoriasis: a randomized controlled clinical trial. Acta Dermato-Venereologica 99(12):1078\u201384","journal-title":"Acta Dermato-Venereologica"},{"key":"1813_CR21","first-page":"550","volume":"41","author":"RP Okhandiar","year":"1963","unstructured":"Okhandiar RP, Banerjee BN (1963) Psoriasis in the tropics: an epidemiological survey. J Ind Med Assoc 41:550\u20136","journal-title":"J Ind Med Assoc"},{"issue":"2","key":"1813_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.25259\/IJDVL_1094_2024","volume":"91","author":"VV Pai","year":"2025","unstructured":"Pai VV, Sarath AP, Kerkar Z (2025) Gut microbiome in dermatology: a narrative review. Ind J Dermatol Venereol Leprol 91(2):1\u201311","journal-title":"Ind J Dermatol Venereol Leprol"},{"issue":"1","key":"1813_CR23","doi-asserted-by":"publisher","DOI":"10.2196\/64277","volume":"14","author":"J Perez-Bootello","year":"2025","unstructured":"Perez-Bootello J, Berna-Rico E, de Aragon CA, Cova-Martin R, Goni L, Ballester-Martinez A, Jaen-Olasolo P, Mehta N, Gelfand JM, Martinez-Gonzalez MA, Gonzalez-Cantero A (2025) Impact of the mediterranean diet on patients with psoriasis: protocol for a randomized controlled trial. JMIR Res Prot 14(1):e64277","journal-title":"JMIR Res Prot"},{"issue":"3","key":"1813_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","volume":"21","author":"A Raharja","year":"2021","unstructured":"Raharja A, Mahil SK, Barker JN (2021) Psoriasis: a brief overview. Clin Med 21(3):170\u20133","journal-title":"Clin Med"},{"issue":"6","key":"1813_CR25","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci 20(6):1475","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1813_CR26","doi-asserted-by":"publisher","first-page":"2430420","DOI":"10.1080\/19490976.2024.2430420","volume":"16","author":"M Rios-Carlos","year":"2024","unstructured":"Rios-Carlos M, L\u00f3pez-Herrera RA, Escamilla-S\u00e1nchez JA, L\u00f3pez-Mac\u00edas C (2024) Unraveling the gut-skin axis in atopic dermatitis: exploiting insights for therapeutic strategies. Gut Microbes 16(1):2430420","journal-title":"Gut Microbes"},{"key":"1813_CR27","doi-asserted-by":"crossref","unstructured":"Sanford JA, Gallo RL (2013) Functions of the skin microbiota in health and disease. In: Seminars in immunology 2013 Nov 30 (Vol. 25, No. 5, pp. 370\u2013377). Academic Press","DOI":"10.1016\/j.smim.2013.09.005"},{"key":"1813_CR28","unstructured":"Shokoohi R, Mosadegh S, Pourrezaei P, Ansari A (2024) Biotics as novel therapeutics in targeting signs of skin ageing via the gut-skin axis. Arch Dermatol Res"},{"key":"1813_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122991","volume":"15","author":"D Sugumaran","year":"2024","unstructured":"Sugumaran D, Yong AC, Stanslas J (2024) Advances in psoriasis research: from pathogenesis to therapeutics. Life Sci 15:122991","journal-title":"Life Sci"},{"issue":"5","key":"1813_CR30","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3390\/biomedicines10051037","volume":"10","author":"AY Thye","year":"2022","unstructured":"Thye AY, Bah YR, Law JW, Tan LT, He YW, Wong SH, Thurairajasingam S, Chan KG, Lee LH, Letchumanan V (2022) Gut\u2013skin axis: unravelling the connection between the gut microbiome and psoriasis. Biomedicines 10(5):1037","journal-title":"Biomedicines"},{"issue":"1","key":"1813_CR31","first-page":"9188","volume":"14","author":"S Widhiati","year":"2021","unstructured":"Widhiati S, Purnomosari D, Wibawa T, Soebono H (2021) The role of gut microbiome in inflammatory skin disorders: a systematic review. Dermatol Rep 14(1):9188","journal-title":"Dermatol Rep"},{"issue":"1","key":"1813_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18023","volume":"28","author":"R Wu","year":"2024","unstructured":"Wu R, Zhao L, Wu Z, Liu X, Li J, Wang T, Zhang L (2024) Psoriasis and gut microbiota: a Mendelian randomization study. J Cell Mol Med 28(1):e18023","journal-title":"J Cell Mol Med"},{"issue":"18","key":"1813_CR33","doi-asserted-by":"publisher","first-page":"e37432","DOI":"10.1016\/j.heliyon.2024.e37432","volume":"10","author":"M Wu","year":"2024","unstructured":"Wu M, Chen X, Lu Q, Yao X (2024) Fecal microbiota transplantation for the treatment of chronic inflammatory skin diseases. Heliyon 10(18):e37432","journal-title":"Heliyon"},{"key":"1813_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/PTT.S505283","volume":"31","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Jing D, Xiao H, Mao M, Kuang Y, Shen M, Lv C, Jian X, Peng C, Chen X (2025) Metagenomics analysis of altered gut microbiome in psoriasis and the mediation analysis: a case-control study. Psoriasis Targets Therapy 31:45\u201354","journal-title":"Psoriasis Targets Therapy"},{"issue":"1","key":"1813_CR35","first-page":"7552546","volume":"2021","author":"L Zeng","year":"2021","unstructured":"Zeng L, Yu G, Wu Y, Hao W, Chen H (2021) The effectiveness and safety of probiotic supplements for psoriasis: a systematic review and meta-analysis of randomized controlled trials and preclinical trials. J Immunol Res 2021(1):7552546","journal-title":"J Immunol Res"},{"issue":"1","key":"1813_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41392-022-01219-0","volume":"8","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Yu J, Zhou H, Wang X, Zhang C, Hu J, Hu Y, Zheng H, Zeng F, Yue C, Gu L (2023) Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism. Signal Trans Target Therapy 8(1):40","journal-title":"Signal Trans Target Therapy"},{"issue":"11","key":"1813_CR37","doi-asserted-by":"publisher","first-page":"1448626","DOI":"10.3389\/fmed.2024.1448626","volume":"6","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Xu F, Chen H, Zheng Q (2024) The efficacy and safety of probiotics in the adjuvant treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials. Front Med 6(11):1448626","journal-title":"Front Med"},{"issue":"14","key":"1813_CR38","doi-asserted-by":"publisher","first-page":"1430586","DOI":"10.3389\/fcimb.2024.1430586","volume":"7","author":"X Zou","year":"2024","unstructured":"Zou X, Zou X, Gao L, Zhao H (2024) Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions. Front Cell Infect Microbiol 7(14):1430586","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01813-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01813-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01813-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:20:54Z","timestamp":1757186454000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01813-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1813"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01813-y","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}